Fundraising Fox

CARLSMED, INC.

NASDAQ: CARL

Carlsbad, US · Founded 2018 · 2 known investors

Biotech

Founders & leadership

KS
Kevin SidowDirector
SH
Shariq HussainExecutive Officer
AA
Alexander ArrowExecutive Officer
JR
Jonathan RootDirector
RM
Robert MittendorffDirector
SS
Sharon SchulzkiExecutive Officer
MC
Michael CordonnierExecutive Officer, Director
PY
Philip YoungDirector
MS
Mark SingerExecutive Officer
NC
Niall CaseyExecutive Officer, Director

Investors · 2

B Capital GroupreportedManhattan Beach · $10M – $50Mvia Robert Mittendorff · board
B4 Capitalreported$10M – $50Mvia Robert Mittendorff · board

Reported raises · per SEC filings

Form D private placements
▶$64.5MraisedFeb 2025 · 7 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert MittendorffDirector
  • Kevin O'BoyleDirector
  • Leonard GreensteinExecutive Officer
  • Durall ScottExecutive Officer
  • Niall CaseyExecutive Officer, Director
  • Philip YoungDirector
  • Michael CordonnierExecutive Officer, Director
  • Kevin SidowDirector
  • Sharon SchulzkiExecutive Officer
  • Shariq HussainExecutive Officer
  • Jonathan RootDirector
Offering amount
$64.5M
Amount sold
$64.5M
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30MraisedApr 2022 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin SidowDirector
  • Shariq HussainExecutive Officer
  • Alexander ArrowExecutive Officer
  • Jonathan RootDirector
  • Robert MittendorffDirector
  • Sharon SchulzkiExecutive Officer
  • Michael CordonnierExecutive Officer, Director
  • Philip YoungDirector
  • Mark SingerExecutive Officer
  • Niall CaseyExecutive Officer, Director
Offering amount
$30M
Amount sold
$30M
First sale
Apr 2022
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.6MraisedDec 2020 · 50 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexander ArrowExecutive Officer
  • Sharon SchulzkiExecutive Officer
  • Niall CaseyExecutive Officer, Director
  • Philip YoungDirector
  • Kevin SidowDirector
  • Shariq HussainExecutive Officer
  • Justin EsterbergExecutive Officer
  • Michael CordonnierExecutive Officer, Director
  • Jonathon RootDirector
Offering amount
$12.6M
Amount sold
$12.6M
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedMay 2020 · 40 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael CordonnierExecutive Officer, Director
  • Jeffrey RohDirector
  • Justin EsterbergExecutive Officer, Director
  • Alexander ArrowExecutive Officer
  • Sharon SchulzkiExecutive Officer
  • Niall CaseyDirector
Offering amount
$2.5M
Amount sold
$2M
First sale
Nov 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.